230 related articles for article (PubMed ID: 34337995)
1. Comparing total medical expenditure between patients receiving direct oral anticoagulants vs warfarin for the treatment of atrial fibrillation: evidence from VA-Medicare dual enrollees.
Wong ES; Done N; Zhao M; Woolley AB; Prentice JC; Mull HJ
J Manag Care Spec Pharm; 2021 Aug; 27(8):1056-1066. PubMed ID: 34337995
[No Abstract] [Full Text] [Related]
2. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation.
Chen N; Brooks MM; Hernandez I
JAMA Netw Open; 2020 Feb; 3(2):e1921357. PubMed ID: 32074287
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant Prescribing for Non-Valvular Atrial Fibrillation in the Veterans Health Administration.
Rose AJ; Goldberg R; McManus DD; Kapoor A; Wang V; Liu W; Yu H
J Am Heart Assoc; 2019 Sep; 8(17):e012646. PubMed ID: 31441364
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
[TBL] [Abstract][Full Text] [Related]
5. Comparative Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients with Atrial Fibrillation.
Briasoulis A; Mentias A; Mazur A; Alvarez P; Leira EC; Vaughan Sarrazin MS
Cardiovasc Drugs Ther; 2021 Apr; 35(2):261-272. PubMed ID: 33404923
[TBL] [Abstract][Full Text] [Related]
6. Comparison of real-world outcomes in patients with nonvalvular atrial fibrillation treated with direct oral anticoagulant agents or warfarin.
Datar M; Crivera C; Rozjabek H; Abbass IM; Xu Y; Pasquale MK; Schein JR; Andrews GA
Am J Health Syst Pharm; 2019 Feb; 76(5):275-285. PubMed ID: 30698654
[TBL] [Abstract][Full Text] [Related]
7. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
8. Direct Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation and Low Body Weight.
Lee SR; Choi EK; Park CS; Han KD; Jung JH; Oh S; Lip GYH
J Am Coll Cardiol; 2019 Mar; 73(8):919-931. PubMed ID: 30819360
[TBL] [Abstract][Full Text] [Related]
9. Comparison of real-world clinical and economic outcomes in patients receiving oral anticoagulants: A retrospective claims analysis.
Karnick C; Modany A; McGraw M; Ludwig J; Marr D; Hammonds T; Good CB; Culley E
J Manag Care Spec Pharm; 2022 Nov; 28(11):1304-1315. PubMed ID: 36282935
[No Abstract] [Full Text] [Related]
10. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
11. A single center retrospective cohort study evaluating use of direct oral anticoagulants (DOACs) in morbidly obese veteran population.
Patil T; Lebrecht M
Thromb Res; 2020 Aug; 192():124-130. PubMed ID: 32473496
[TBL] [Abstract][Full Text] [Related]
12. Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities.
Essien UR; Kim N; Magnani JW; Good CB; Litam TMA; Hausmann LRM; Mor MK; Gellad WF; Fine MJ
Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008389. PubMed ID: 34779655
[TBL] [Abstract][Full Text] [Related]
13. The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015.
Alamneh EA; Chalmers L; Bereznicki LR
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28177198
[TBL] [Abstract][Full Text] [Related]
14. Anticoagulation Therapy for Atrial Fibrillation in Patients With Alzheimer's Disease.
Ruiz Vargas E; Sposato LA; Lee SAW; Hachinski V; Cipriano LE
Stroke; 2018 Dec; 49(12):2844-2850. PubMed ID: 30571418
[TBL] [Abstract][Full Text] [Related]
15. Group based trajectory modeling to assess adherence to oral anticoagulants among atrial fibrillation patients with comorbidities: a retrospective study.
Mohan A; Majd Z; Trinh T; Paranjpe R; Abughosh SM
Int J Clin Pharm; 2022 Aug; 44(4):966-974. PubMed ID: 35776377
[TBL] [Abstract][Full Text] [Related]
16. Guideline-concordant initiation of oral anticoagulant therapy for stroke prevention in older veterans with atrial fibrillation eligible for Medicare Part D.
Done N; Roy AM; Yuan Y; Pizer SD; Rose AJ; Prentice JC
Health Serv Res; 2019 Feb; 54(1):128-138. PubMed ID: 30417341
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Bioprosthetic Heart Valves.
Duan L; Doctor JN; Adams JL; Romley JA; Nguyen LA; An J; Lee MS
Am J Cardiol; 2021 May; 146():22-28. PubMed ID: 33529622
[TBL] [Abstract][Full Text] [Related]
18. Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation.
Alalwan AA; Voils SA; Hartzema AG
Am J Health Syst Pharm; 2017 Aug; 74(16):1237-1244. PubMed ID: 28652320
[TBL] [Abstract][Full Text] [Related]
19. Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillation.
Peterson ED; Ashton V; Chen YW; Wu B; Spyropoulos AC
Am Heart J; 2019 Jun; 212():113-119. PubMed ID: 30981035
[TBL] [Abstract][Full Text] [Related]
20. Apixaban Dosing Patterns Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation Receiving Dialysis: A Retrospective Cohort Study.
Wetmore JB; Weinhandl ED; Yan H; Reyes JL; Herzog CA; Roetker NS
Am J Kidney Dis; 2022 Nov; 80(5):569-579.e1. PubMed ID: 35469965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]